Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Breast Cancer
- Lung Cance
- Melanoma
- Type
- Observational
- Design
- Observational Model: OtherTime Perspective: Prospective
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04234620
- Collaborators
- Not Provided
- Investigators
- Not Provided